Evidence map›Paper›PMID 37132761›Full record

ArticleRevista paulista de pediatria : orgao oficial da Sociedade de Pediatria de Sao Paulo2023

Role of the NF-kB/parkin/vegfr-1 pathway associated with hypoxic-ischemic insult in germinal matrix samples of newborn infants.

Eliane Amaral Ghirelli, Felipe Paes Gomes da Silva, Alessandro Gonçalves Gomes Oricil, Caroline Busatta Vaz de Paula, Seigo Nagashima, Carlos Frederico Oldenburg Neto, Eduardo Storti, Fernando Yochiteru Rolim Sakiyama, Rafael Martins Kayano, Renata Rolim Sakiyama and 3 more

Open access · diamondAbstract read
In one paragraph

Article in Revista paulista de pediatria : orgao oficial da Sociedade de Pediatria de Sao Paulo, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Eliane Amaral GhirelliPontifícia Universidade Católica do Paraná, Curitiba, PR, Brazil.ORCID http://orcid.org/0000-0002-6566-7469
Felipe Paes Gomes da SilvaPontifícia Universidade Católica do Paraná, Curitiba, PR, Brazil.ORCID http://orcid.org/0000-0002-5360-3281
Alessandro Gonçalves Gomes OricilPontifícia Universidade Católica do Paraná, Curitiba, PR, Brazil.ORCID http://orcid.org/0000-0001-9916-3069
Caroline Busatta Vaz de PaulaPontifícia Universidade Católica do Paraná, Curitiba, PR, Brazil.ORCID http://orcid.org/0000-0002-8434-8471
Seigo NagashimaPontifícia Universidade Católica do Paraná, Curitiba, PR, Brazil.ORCID http://orcid.org/0000-0003-0069-3823
Carlos Frederico Oldenburg NetoPontifícia Universidade Católica do Paraná, Curitiba, PR, Brazil.ORCID http://orcid.org/0000-0001-8034-2251
Eduardo StortiPontifícia Universidade Católica do Paraná, Curitiba, PR, Brazil.ORCID http://orcid.org/0000-0002-1936-7561
Fernando Yochiteru Rolim SakiyamaUniversidade Federal do Paraná, Curitiba, PR, Brazil.ORCID http://orcid.org/0000-0003-3842-0927
Rafael Martins KayanoUniversidade Federal do Paraná, Curitiba, PR, Brazil.ORCID http://orcid.org/0000-0001-6405-871X
Renata Rolim SakiyamaUniversidade Federal do Paraná, Curitiba, PR, Brazil.ORCID http://orcid.org/0000-0001-6956-5083
Vinícius da Silva MoreiraUniversidade Federal do Paraná, Curitiba, PR, Brazil.ORCID http://orcid.org/0000-0002-5586-4637
Vanessa Santos SotomaiorPontifícia Universidade Católica do Paraná, Curitiba, PR, Brazil.ORCID http://orcid.org/0000-0001-5388-6384
Lucia de NoronhaPontifícia Universidade Católica do Paraná, Curitiba, PR, Brazil.ORCID http://orcid.org/0000-0003-0310-7164
Pontifícia Universidade Católica do Paraná · BRUniversidade Federal do Paraná · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveGiven the high proliferative activity of germinal matrix and its direct correlation with hypoxemia, it is necessary to investigate the possible molecular regulation pathways, to understand the existing clinical relationship between the hypoxic-ischemic insult and the biomarkers NF-kB, AKT-3, Parkin, TRK-C and VEGFR-1.

methodsA hundred and eighteen germinal matrix samples of the central nervous system of patients who died in the first 28 days of life were submitted to histological and immunohistochemistry analysis to identify the tissue immunoexpression of those biomarkers related to asphyxia, prematurity, and death events within 24h.

resultsA significantly increased tissue immunoexpression of NF-kB, AKT-3 and Parkin was observed in the germinal matrix of preterm infants. In addition, significantly decreased tissue immunoexpression of VEGFR-1 and NF-kB was observed in patients who experienced asphyxia followed by death within 24 hours.

conclusionsThe results suggest a direct involvement between the hypoxic-ischemic insult and NF-kB and VEGFR-1 markers since a decreased immunoexpression of these biomarkers was observed in asphyxiated patients. Furthermore, it is suggested that there was not enough time for VEGFR-1 to be transcribed, translated and expressed on the surface of the plasma membrane. This temporality can be observed in the relationship between NF-kB expression and the survival time of individuals who died within 24 hours, suggesting that this factor is essential for the production of VEGFR-1 and, therefore, to carry out the necessary remodeling effect to neovascularize the affected region.

Indexed as

Infant, PrematureNF-kappa BAsphyxiaBiomarkersHumansHypoxiaInfant, NewbornProto-Oncogene Proteins c-aktVascular Endothelial Growth Factor Receptor-1BiomarkersNF-kappa BProto-Oncogene Proteins c-aktVascular Endothelial Growth Factor Receptor-1

Identifiers

PMID37132761
PMCPMC10144076
OpenAlexW4367334650

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.